Michael M. Barnes
Tuesday, September 25, 2018
Shingles Vaccine Shortages Result From High Demand
Shingrix, the vaccine approved last year to prevent shingles, has proved so popular that its maker, GlaxoSmithKline, has not been able to produce it quickly enough.
from Well https://ift.tt/2xBc2Ys
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment